Global Artemisinin Antimalarial Drugs Market Insights and Forecast to 2028

Table Of Contents

1 Study Coverage

1.1 Artemisinin Antimalarial Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Artemisinin Antimalarial Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Artesunate 1.2.3 Dihydroartemisinin 1.2.4 Artemether 1.3 Market by Application 1.3.1 Global Artemisinin Antimalarial Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Prevention 1.3.3 Treatment 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered2 Executive Summary 2.1 Global Artemisinin Antimalarial Drugs Sales Estimates and Forecasts 2017-2028 2.2 Global Artemisinin Antimalarial Drugs Revenue Estimates and Forecasts 2017-2028 2.3 Global Artemisinin Antimalarial Drugs Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Artemisinin Antimalarial Drugs Sales by Region 2.4.1 Global Artemisinin Antimalarial Drugs Sales by Region (2017-2022) 2.4.2 Global Sales Artemisinin Antimalarial Drugs by Region (2023-2028) 2.5 Global Artemisinin Antimalarial Drugs Revenue by Region 2.5.1 Global Artemisinin Antimalarial Drugs Revenue by Region (2017-2022) 2.5.2 Global Artemisinin Antimalarial Drugs Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa3 Competition by Manufacturers 3.1 Global Artemisinin Antimalarial Drugs Sales by Manufacturers 3.1.1 Global Top Artemisinin Antimalarial Drugs Manufacturers by Sales (2017-2022) 3.1.2 Global Artemisinin Antimalarial Drugs Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Artemisinin Antimalarial Drugs in 2021 3.2 Global Artemisinin Antimalarial Drugs Revenue by Manufacturers 3.2.1 Global Artemisinin Antimalarial Drugs Revenue by Manufacturers (2017-2022) 3.2.2 Global Artemisinin Antimalarial Drugs Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Artemisinin Antimalarial Drugs Revenue in 2021 3.3 Global Artemisinin Antimalarial Drugs Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Artemisinin Antimalarial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Artemisinin Antimalarial Drugs Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans4 Market Size by Type 4.1 Global Artemisinin Antimalarial Drugs Sales by Type 4.1.1 Global Artemisinin Antimalarial Drugs Historical Sales by Type (2017-2022) 4.1.2 Global Artemisinin Antimalarial Drugs Forecasted Sales by Type (2023-2028) 4.1.3 Global Artemisinin Antimalarial Drugs Sales Market Share by Type (2017-2028) 4.2 Global Artemisinin Antimalarial Drugs Revenue by Type 4.2.1 Global Artemisinin Antimalarial Drugs Historical Revenue by Type (2017-2022) 4.2.2 Global Artemisinin Antimalarial Drugs Forecasted Revenue by Type (2023-2028) 4.2.3 Global Artemisinin Antimalarial Drugs Revenue Market Share by Type (2017-2028) 4.3 Global Artemisinin Antimalarial Drugs Price by Type 4.3.1 Global Artemisinin Antimalarial Drugs Price by Type (2017-2022) 4.3.2 Global Artemisinin Antimalarial Drugs Price Forecast by Type (2023-2028)5 Market Size by Application 5.1 Global Artemisinin Antimalarial Drugs Sales by Application 5.1.1 Global Artemisinin Antimalarial Drugs Historical Sales by Application (2017-2022) 5.1.2 Global Artemisinin Antimalarial Drugs Forecasted Sales by Application (2023-2028) 5.1.3 Global Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2028) 5.2 Global Artemisinin Antimalarial Drugs Revenue by Application 5.2.1 Global Artemisinin Antimalarial Drugs Historical Revenue by Application (2017-2022) 5.2.2 Global Artemisinin Antimalarial Drugs Forecasted Revenue by Application (2023-2028) 5.2.3 Global Artemisinin Antimalarial Drugs Revenue Market Share by Application (2017-2028) 5.3 Global Artemisinin Antimalarial Drugs Price by Application 5.3.1 Global Artemisinin Antimalarial Drugs Price by Application (2017-2022) 5.3.2 Global Artemisinin Antimalarial Drugs Price Forecast by Application (2023-2028)6 North America 6.1 North America Artemisinin Antimalarial Drugs Market Size by Type 6.1.1 North America Artemisinin Antimalarial Drugs Sales by Type (2017-2028) 6.1.2 North America Artemisinin Antimalarial Drugs Revenue by Type (2017-2028) 6.2 North America Artemisinin Antimalarial Drugs Market Size by Application 6.2.1 North America Artemisinin Antimalarial Drugs Sales by Application (2017-2028) 6.2.2 North America Artemisinin Antimalarial Drugs Revenue by Application (2017-2028) 6.3 North America Artemisinin Antimalarial Drugs Market Size by Country 6.3.1 North America Artemisinin Antimalarial Drugs Sales by Country (2017-2028) 6.3.2 North America Artemisinin Antimalarial Drugs Revenue by Country (2017-2028) 6.3.3 United States 6.3.4 Canada7 Europe 7.1 Europe Artemisinin Antimalarial Drugs Market Size by Type 7.1.1 Europe Artemisinin Antimalarial Drugs Sales by Type (2017-2028) 7.1.2 Europe Artemisinin Antimalarial Drugs Revenue by Type (2017-2028) 7.2 Europe Artemisinin Antimalarial Drugs Market Size by Application 7.2.1 Europe Artemisinin Antimalarial Drugs Sales by Application (2017-2028) 7.2.2 Europe Artemisinin Antimalarial Drugs Revenue by Application (2017-2028) 7.3 Europe Artemisinin Antimalarial Drugs Market Size by Country 7.3.1 Europe Artemisinin Antimalarial Drugs Sales by Country (2017-2028) 7.3.2 Europe Artemisinin Antimalarial Drugs Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia8 Asia Pacific 8.1 Asia Pacific Artemisinin Antimalarial Drugs Market Size by Type 8.1.1 Asia Pacific Artemisinin Antimalarial Drugs Sales by Type (2017-2028) 8.1.2 Asia Pacific Artemisinin Antimalarial Drugs Revenue by Type (2017-2028) 8.2 Asia Pacific Artemisinin Antimalarial Drugs Market Size by Application 8.2.1 Asia Pacific Artemisinin Antimalarial Drugs Sales by Application (2017-2028) 8.2.2 Asia Pacific Artemisinin Antimalarial Drugs Revenue by Application (2017-2028) 8.3 Asia Pacific Artemisinin Antimalarial Drugs Market Size by Region 8.3.1 Asia Pacific Artemisinin Antimalarial Drugs Sales by Region (2017-2028) 8.3.2 Asia Pacific Artemisinin Antimalarial Drugs Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia9 Latin America 9.1 Latin America Artemisinin Antimalarial Drugs Market Size by Type 9.1.1 Latin America Artemisinin Antimalarial Drugs Sales by Type (2017-2028) 9.1.2 Latin America Artemisinin Antimalarial Drugs Revenue by Type (2017-2028) 9.2 Latin America Artemisinin Antimalarial Drugs Market Size by Application 9.2.1 Latin America Artemisinin Antimalarial Drugs Sales by Application (2017-2028) 9.2.2 Latin America Artemisinin Antimalarial Drugs Revenue by Application (2017-2028) 9.3 Latin America Artemisinin Antimalarial Drugs Market Size by Country 9.3.1 Latin America Artemisinin Antimalarial Drugs Sales by Country (2017-2028) 9.3.2 Latin America Artemisinin Antimalarial Drugs Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina10 Middle East and Africa 10.1 Middle East and Africa Artemisinin Antimalarial Drugs Market Size by Type 10.1.1 Middle East and Africa Artemisinin Antimalarial Drugs Sales by Type (2017-2028) 10.1.2 Middle East and Africa Artemisinin Antimalarial Drugs Revenue by Type (2017-2028) 10.2 Middle East and Africa Artemisinin Antimalarial Drugs Market Size by Application 10.2.1 Middle East and Africa Artemisinin Antimalarial Drugs Sales by Application (2017-2028) 10.2.2 Middle East and Africa Artemisinin Antimalarial Drugs Revenue by Application (2017-2028) 10.3 Middle East and Africa Artemisinin Antimalarial Drugs Market Size by Country 10.3.1 Middle East and Africa Artemisinin Antimalarial Drugs Sales by Country (2017-2028) 10.3.2 Middle East and Africa Artemisinin Antimalarial Drugs Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia11 Company Profiles 11.1 Novartis 11.1.1 Novartis Corporation Information 11.1.2 Novartis Overview 11.1.3 Novartis Artemisinin Antimalarial Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Novartis Artemisinin Antimalarial Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Novartis Recent Developments 11.2 Sanofi 11.2.1 Sanofi Corporation Information 11.2.2 Sanofi Overview 11.2.3 Sanofi Artemisinin Antimalarial Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Sanofi Artemisinin Antimalarial Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Sanofi Recent Developments 11.3 Ajanta 11.3.1 Ajanta Corporation Information 11.3.2 Ajanta Overview 11.3.3 Ajanta Artemisinin Antimalarial Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Ajanta Artemisinin Antimalarial Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Ajanta Recent Developments 11.4 Cipla 11.4.1 Cipla Corporation Information 11.4.2 Cipla Overview 11.4.3 Cipla Artemisinin Antimalarial Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Cipla Artemisinin Antimalarial Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Cipla Recent Developments 11.5 Ipca 11.5.1 Ipca Corporation Information 11.5.2 Ipca Overview 11.5.3 Ipca Artemisinin Antimalarial Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Ipca Artemisinin Antimalarial Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Ipca Recent Developments 11.6 Guilin Medicine 11.6.1 Guilin Medicine Corporation Information 11.6.2 Guilin Medicine Overview 11.6.3 Guilin Medicine Artemisinin Antimalarial Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Guilin Medicine Artemisinin Antimalarial Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Guilin Medicine Recent Developments 11.7 GlaxoSmithKline 11.7.1 GlaxoSmithKline Corporation Information 11.7.2 GlaxoSmithKline Overview 11.7.3 GlaxoSmithKline Artemisinin Antimalarial Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 GlaxoSmithKline Artemisinin Antimalarial Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 GlaxoSmithKline Recent Developments 11.8 Mylan Labs 11.8.1 Mylan Labs Corporation Information 11.8.2 Mylan Labs Overview 11.8.3 Mylan Labs Artemisinin Antimalarial Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Mylan Labs Artemisinin Antimalarial Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Mylan Labs Recent Developments 11.9 Roche 11.9.1 Roche Corporation Information 11.9.2 Roche Overview 11.9.3 Roche Artemisinin Antimalarial Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Roche Artemisinin Antimalarial Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Roche Recent Developments12 Industry Chain and Sales Channels Analysis 12.1 Artemisinin Antimalarial Drugs Industry Chain Analysis 12.2 Artemisinin Antimalarial Drugs Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Artemisinin Antimalarial Drugs Production Mode & Process 12.4 Artemisinin Antimalarial Drugs Sales and Marketing 12.4.1 Artemisinin Antimalarial Drugs Sales Channels 12.4.2 Artemisinin Antimalarial Drugs Distributors 12.5 Artemisinin Antimalarial Drugs Customers13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Artemisinin Antimalarial Drugs Industry Trends 13.2 Artemisinin Antimalarial Drugs Market Drivers 13.3 Artemisinin Antimalarial Drugs Market Challenges 13.4 Artemisinin Antimalarial Drugs Market Restraints14 Key Findings in The Global Artemisinin Antimalarial Drugs Study15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer